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N-Terminal amino acid sequence analysis by Edman’s phenylisothiocyanate method on intact human fibrinogen 
revealed the Fist seven amino acids of the T-chain: H-Tyr-Val-Ala-Thr-Arg-Asp-Asn-. 
1. Introduction 2. Materials and methods 
The fibrogen molecule is most likely composed of two Fibrinogen. A 1.82% solution of purified, dialyzed 
identical subunits, each having a molecular weight of about human fibrinogen (Fraction I-4) in 0.3 M NaCl was 
170,000 and 3 different peptide chains named a(A), 
p(B) and y [ 1,2] . By the action of thrombin, fibrin& 
peptide A is released from the al(A)-chain and fibrino- 
peptide B from the fl(B)-chain. The -y-chain is not sus- 
ceptible to hydrolysis by thrombin. The fibrinopeptides 
are located at the N-terminal end of the fibrinogen mo- 
lecule [3,4] . The amino acid sequences of the fibrino- 
peptides are known for several species [5] . Since the 
N-terminal amino acid of the human fibrinopeptide B 
is a pyrogiutamyl residue [6] and therefore not de- 
gradable by the phenylisothiocyanate method [7], 
sequence analysis of the whole human fibrinogen should 
yield only two amino acids for each step, one belonging 
to the ol(A)-chain and the other to the y-chain. Since 
the N-terminal sequence of the a(A)ch is known, 
the sequence of the r-chain should be deducible by 
stepwise degradation of whole fibrinogen. 
In the present study, radioactive phenylisothiocyan- 
ate-35s was used for stepwise degradation of milligram 
quantities of human fibrinogen. This allowed a quan- 
titative estimation of the PTH-amino acids and facili- 
tated their identification on the thin-layer chromato- 
grams. The results have been referred to in a previous 
publication [ I] . 
Abbreviations: 
PTH- = phenylthiohydantoin- 
PTC- = phenylthiocarbamyl- 
North-Holland Publishing Company - Amsterdam 
used [8] . Coagulability was around 98%. 
Phenylisothiocyanate-35S was obtained from the 
Radiochemical Centre, Amersham, England. (Cat. 
No SJ 95). Specific activity was 25-30 #Zi/pmole. 
Before use freshly distilled carrier phenylisothiocyanate 
was added. 
Thin-layer chromatography was performed in silica- 
gel (0.5 mm) containing 0.5% starch, 0.1% EDTA and 
fluorescence indicator. The plates were 20 cm X 20 cm. 
The silica was Camag Type DF 5. The two-dimensional 
scanner of Berthold, Wildbad, Germany was used for 
localization and quantitation of radioactivity in the 
spots. The instrument is provided with equipment for 
automatic registration of radioactivity (counts per min) 
as well integration of the peaks. 
Sequence analysis. The three-stage phenylisothio- 
cyanate method of Edman [7,9, lo] was used. The 
details of the procedure have been described elsewhere 
[4, Ill. To duplicate samples of 0.75 ml (13.7 mg) of 
fibrinogen solution was added 1 ml of pyridine and 
0.5 N NaOH to adjust to the pH to 8.5-9. After flush- 
ing the mixture with nitrogen 25 ~1 of phenylisothio- 
cyanate-35s (specific activity: 2-3 &i/pmole) was 
added. The mixture was incubated for 2 hr at room 
temperature. If necessary the pH was adjusted to 9 
with NaOH. Washing of the IPTC-protein with benzene 
(2-3 ml), precipitation with acetone (5 ml) and wash- 
ing with aqueous acetone (3 ml) was a previously des- 
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cribed [ 1 l] . The lyophilized PTC-protein was subjected 
to cleavage in trifluoroacetic acid (0.1 ml) at 40” for 20 
min and the residual protein precipitated with ethyl- 
enechloride (3 ml) [4]. The thiazolinones contained in 
the ethylenechloride phase were subsequently converted 
to PTHderivatives in N HCl(0.3 ml) at 80”. The PTH- 
amino acids were extracted from the aqueous solution 
with ethylenechloride [4] . The solvent was evaporated 
and the PTH-amino acids dissolved in 90% acetic acid 
(25 ~1) for thin-layer chromatography. PTH-derivatives 
left in the water-phase were identified by electropho- 
resis. The protein residue left after extraction with 
ethylenechloride was lyophilized and used for the next 
degradation cycle. 
In the second and following degradation cycles di- 
methyl-allylamine (DMAA) buffer, pH 9.5, containing 
pyridine was used for the coupling reaction [4] . The 
protein was suspended in 1 ml of buffer. It was rather 
insoluble in the solvent but could be suspended evenly 
by crushing and vigorous “whirl-mixing”. After coupling 
with phenylisothiocyanate-3% the samples were washed 
5 times with benzene (about 1.5 ml). The water-phase 
was lyophilized and the residues extracted with ethyl- 
acetate (0.5 ml, 3 times) [6]. Next the residual PTC- 
protein was cleaved with trifluoroacetic acid. This and 
the following procedure were the same as described 
above for the first degradation cycle. 
PTH-3SS-tyrosine standard. A PTH-35S-tyrosine 
standard was prepared from 0.5 pmoles of tyrosine 
using the same radioactive phenylisothiocyanate-3% 
and essentially the same conditions as described above 
for the sequence analysis in the second degradation 
cycle. However, because of the solubility properties 
of PTC-tyrosine washing with ethyl-acetate was omitted. 
After thorough washing with benzene the water-phase 
was lyophilized. The PTC-derivative was converted 
to the flH-derivative in HCl as described above. 
Thin-layer chromatography and electrophoresis. 
Aliquots (1-3 1.11) of the samples, PTH-35S-tyrosine 
standard and reference PTH-amino acids were chroma- 
tographed on thin-layers of silica gel. Solvents D and E 
of Edman and Sjaquist [ 121 and II and III of Brenner 
et al. [ 131 were generally used. To distinguish PTH- 
valine from PTH-phenylalanine system V of Jeppsson 
and Sjijquist [ 141 was used. 
After drying the plates were mounted on the scan- 
ner table. The radioactivity (counts per min) was re- 
gistered and integrated. The yields of the unknown 
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PTH-35S-amino acid samples were calculated from the 
PTH-35S-tyrosine standard curve. 
After scanning, the plates were checked under UV- 
light, sprayed with the iodine azide reagent [ 151 and 
photographed. By comparison with the reference PTH- 
amino acids the unknown PTH-amino acids could be 
unequivocally identified. 
The aqueous phases were examined by means of 
paper electrophoresis [161 for demonstration of PTH- 
derivatives of histidine and arginine. No quantitation 
of those amino acids was attempted. 
3. Results 
Intact human fibrinogen, degraded stepwise by the 
Edman method through seven cycles, yielded as ex- 
pected two major amino acids for each step. Since one 
set corresponded exactly to the known N-terminal se- 
quence of the fibrinopeptide A, the N-terminal sequence 
of the y-chain could be easily deduced as: 
H-Tyr-V;l-A?-Tp-A;g-A;p--AT-- (table 1). 
Traces of other PTH-amino acids were also observed 
in each cycle. These possibly derived from the chain 
variant a(AY) [6]. However, only the residues of the 
cu(A)- and a(AP)-chain have been quantitatively deter- 
mined. Other unidentifiable derivatives were occasional- 
ly observed. The latter, with two exceptions, did not 
influence the quantitative determination, since they 
could be chromatographically separated from the main 
PTH-amino acids in at least one of the solvent systems. 
In step 3, multiple radioactive spots due to decom- 
position products of serine were found, thus rendering 
quantitative determination of serine in the cw(A)-chain 
impossible. Quantitation of PTH-alanine from the y- 
chain however, seemed not to be influenced by the 
degradation products (table 1). In step 4, about 2/3 
of the threonine was present as PTHdehydrothreonine. 
This could not be determined accurately since it was 
not in any of the solvents completely separated from 
other side reaction products. The PTH-derivative of 
arginine was found in the aqueous phase of step 5. The 
electrophoretic mobility and the positive Sakaguchi 
reaction indicated arginine. The yield of the PTH- 
glycine in the sixth degradation cycle seems to be 
somewhat high. It is likely that monophenylthiourea 
which has about the same Rfvalue as glycine is inter- 
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Stepwise degradation of intact human fibrinogen. 
Step PTH-amino 
acid 
O!(A)Chain 
Totala 
mnoles 
wales/ PTH-amino 
170 mg acid 
T-Chain 
Totala 
nmoles 
rmoles/ 
170 mg 
1 Ala 36 .O (4) 0.45 Tyr 66.0 ( 4) 0.82 
2 Asp 23.9 (6) 0.30 Val 60.7 (17) 0.75 
3 Ser b - Ala 41.1 (12) 0.51 
4 GlY 27.5 (6) 0.34 Thrc 14.0 ( 6) 0.17 
5 Glu 18.8 (6) 0.23 AI8 presentd - 
6 Gly 42.1 (5) 0.52 Asp 28.5 ( 5) 0.35 
7 Asp 27.3 (8) 0.34 ASrl 19.1 ( 8) 0.24 
a mean values of 2 samples, numbers of scannings inparenthesis. 
b quant. determination not possible. 
c PTH-dehydrothreonine not determined. 
d not quantitatively determined. 
fering in this step. Beginning at step 4, some overlap- 
ping between successive steps was observed. The quan- 
titative estimation, however, allowed a clear distinc- 
tion of the main PTH-amino acids. 
4. Discussion 
The existing evidence [l ,3,4, 171 that fibrino- 
peptide A is an N-terminal fragment of fibrinogen is 
further substantiated by the present findings. Stepwise 
degradation of the intact fibrinogen molecule resulted 
in residues corresponding to the first seven amino acids 
of the fibrinopeptide A. Furthermore, the first seven 
amino acids of the y-chain could be deduced. This in- 
formation made it possible to identify the N-terminal 
y-chain fragment in fibrinogen degraded with cyanogen 
bromide [l, 181. 
The N-terminal portions of fibrinopeptides A and 
B of various mammals show a high variability in se- 
quence [S] . The T-chain may have a more constant 
structure in the N-terminal region. N-terminal tyrosine 
is found in fibrinogen of at least seven mammalian 
species [ 1 l] . Pirkle et al. [ 191 have found in the T-chain 
of bovine fibrinogen the same sequence for seven re- 
sidues as in human fibrinogen. In the corresponding 
portion of the ychain of pig fibrinogen there was only 
one substitution, glutamic acid substituted for aspartic 
acid at position 6. 
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